Xie Ying
Overview
Explore the profile of Xie Ying including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang M, Zheng C, Zhou F, Ying X, Zhang X, Peng C, et al.
J Gastroenterol Hepatol
. 2024 Nov;
40(3):666-676.
PMID: 39586593
Inflammatory bowel disease (IBD) is an inflammatory disease that occurs to the intestinal tract. Many patients with IBD often develop anemia and often receive oral iron supplementation. Many of them...
2.
Yongpeng Z, Yaxing W, Jinqiong Z, Qian W, Yanni Y, Xuan Y, et al.
Front Public Health
. 2022 Aug;
10:922289.
PMID: 35923972
This study aimed to investigate the prevalence of age-related macular degeneration (AMD) in patients with diabetes mellitus (DM) and diabetic retinopathy (DR) and analyze whether DR is a risk factor...
3.
Weiwei G, Xuexing Z, Chong W, Yongkun Z, Qi W, Hualei W, et al.
J Med Virol
. 2017 Apr;
89(12):2069-2074.
PMID: 28402024
Marburg virus (MARV), which is one of the most virulent agents in the world, causes lethal haemorrhagic fever in humans and nonhuman primates (NHPs) with a mortality rate of up...
4.
Halegoua-De Marzio D, Kraft W, Daskalakis C, Ying X, Hawke R, Navarro V
Clin Ther
. 2012 Nov;
34(12):2279-2285.e1.
PMID: 23153661
Background: Epigallocatechin-3-gallate (EGCG) has antiangiogenic, antioxidant, and antifibrotic properties that may have therapeutic potential for the treatment of cirrhosis induced by hepatitis C virus (HCV). However, cirrhosis might affect EGCG...